Voiding Dysfunction/BPH
Steven Kaplan, Dr.
Professor of Urology
Icahn School of Medicine at Mount Sinai
Lori Lerner, MD (she/her/hers)
Boston University School of Medicine
Kevin McVary, MD
Professor
Loyola University Medical Center
.jpg "Claus Roehrborn, MD (he/him/his) photo")
Claus Roehrborn, MD (he/him/his)
Department Chair
UT Southwestern Medical Center
Alexis Te, MD
Professor
Icahn School of Medicine at Mount Sinai
Course Description: The diagnosis and management of male lower urinary tract symptoms (mLUTS) and benign prostatic hyperplasia (BPH) have evolved and are reflected in the AUA BPH Guidelines with important and newly changing algorithms. This course with an outstanding faculty with firsthand experience on all the relevant clinical trials is designed to review, discuss and develop a coherent diagnostic and treatment strategy for men with mLUTS utilizing these new Guidelines. More specifically, this will use clinical scenarios with audience participation in an effort to demonstrate new diagnostic algorithms, and the use of preoperative ultrasound and noninvasive pressure-flow studies. Medical therapy with both monotherapy and combination therapy with agents such as alpha blockers, antimuscarinics, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors and beta3-agonists will be used in clinical scenarios to enhance appropriate use. With the advancement of multiple new minimally invasive surgical options including UroLift®, convective water vapor therapy, I-TindÔ and prostate artery embolization, and surgical options including Aquablation® and updates on the role of electrosurgical and laser techniques, a better understanding of how the BPH Guidelines can be used to properly diagnose, treat and manage postoperative sequelae. Urologists need to be cognizant of how these new therapies align with the current Guidelines. In addition, how these agents dovetail with sexual function and testosterone replacement therapy will be highlighted. Finally, pharmacoeconomics and the impact of long-term therapy as well as surgical outcomes will be debated.